Bradley S Quon1, Christopher H Goss. 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington Medical Center, Seattle, Washington 98195, USA.
Abstract
BACKGROUND: Continuous quality improvement (CQI) in healthcare can be described as a reiterative approach to improving processes to reduce unexpected variation in health outcomes. CQI represents one model to achieve quality improvement (QI) and has long been recognized as a key to success in the manufacturing industry with companies like Toyota leading the way. OBJECTIVE: Healthcare, and specifically pulmonary, critical care and sleep medicine represent ideal settings for the application of CQI. METHODS: This opinion piece will describe QI and CQI initiatives in the US Cystic fibrosis (CF) population. RESULTS: QI in CF care in the United States has been ongoing since inception of the US CF Foundation (CFF) in 1955. This effort has included work to improve the quality of clinical care provided at CF centers and work to improve clinical outcomes in CF. More recently, QI methods have been applied to the conduct of clinical research. CONCLUSIONS: The CF community has become a leader in the area of QI and has pointed out the opportunities for others to follow in the area of lung diseases.
BACKGROUND: Continuous quality improvement (CQI) in healthcare can be described as a reiterative approach to improving processes to reduce unexpected variation in health outcomes. CQI represents one model to achieve quality improvement (QI) and has long been recognized as a key to success in the manufacturing industry with companies like Toyota leading the way. OBJECTIVE: Healthcare, and specifically pulmonary, critical care and sleep medicine represent ideal settings for the application of CQI. METHODS: This opinion piece will describe QI and CQI initiatives in the US Cystic fibrosis (CF) population. RESULTS: QI in CF care in the United States has been ongoing since inception of the US CF Foundation (CFF) in 1955. This effort has included work to improve the quality of clinical care provided at CF centers and work to improve clinical outcomes in CF. More recently, QI methods have been applied to the conduct of clinical research. CONCLUSIONS: The CF community has become a leader in the area of QI and has pointed out the opportunities for others to follow in the area of lung diseases.
Authors: Geoffrey C Nguyen; Shane M Devlin; Waqqas Afif; Brian Bressler; Steven E Gruchy; Gilaad G Kaplan; Liliana Oliveira; Sophie Plamondon; Cynthia H Seow; Chadwick Williams; Karen Wong; Brian M Yan; Jennifer Jones Journal: Can J Gastroenterol Hepatol Date: 2014-05
Authors: Michele A Scully; Valerie A Cwik; Bruce C Marshall; Emma Ciafaloni; Jodi M Wolff; Thomas S Getchius; Robert C Griggs Journal: Neurology Date: 2013-02-05 Impact factor: 9.910
Authors: Steven M Rowe; Drucy S Borowitz; Jane L Burns; John P Clancy; Scott H Donaldson; George Retsch-Bogart; Scott D Sagel; Bonnie W Ramsey Journal: Thorax Date: 2012-10 Impact factor: 9.139
Authors: The Thanh-Diem Nguyen; Lena P Thia; Ah-Fong Hoo; Andrew Bush; Paul Aurora; Angie Wade; Jane Chudleigh; Sooky Lum; Janet Stocks Journal: Thorax Date: 2013-09-26 Impact factor: 9.139